CAH
Cardinal Health, Inc. · Healthcare · Medical - Distribution
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +0.8% · netto nieuwe posities -4.5% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 96.00K | $22.40M | n/a | −2 |
| Q2 2026 | 169 | +5 | 162.32M | $38.54B | +9 | −6 |
| Q1 2026 | 169 | -3 | 156.75M | $33.07B | n/a | −4 |
| Q4 2025 | 171 | +1 | 178.08M | $36.60B | +2 | n/a |
| Q3 2025 | 22 | 0 | 113.76M | $17.85B | +1 | −2 |
| Q2 2025 | 20 | 0 | 103.35M | $17.36B | +1 | −1 |
| Q1 2025 | 17 | -1 | 36.99M | $5.09B | n/a | −1 |
| Q4 2024 | 18 | 0 | 42.27M | $5.00B | +1 | −1 |
| Q3 2024 | 17 | 0 | 26.27M | $2.90B | n/a | n/a |
| Q2 2024 | 17 | n/a | 25.18M | $2.47B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 31.46M | +3.0% | $4.94B | 0.1% | ▲ Add | 2 | SEC ↗ ×21 |
| 2 | The Vanguard Group ✦ (passief) | 30.82M | +0.8% | $4.84B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 12.29M | -3.0% | $1.93B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 6.49M | +1.5% | $1.01B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 5.80M | +153.2% | $911.01M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 6 | JPMorgan Chase ✦ | 5.80M | n/a | $909.97M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 7 | Fidelity (FMR) ✦ | 5.42M | -13.6% | $850.73M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 8 | Morgan Stanley ✦ | 5.23M | n/a | $820.95M | 0.1% | n/c | 1 | SEC ↗ ×16 |
| 9 | Millennium Management ✦ | 1.98M | +55.3% | $311.48M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 1.98M | n/a | $310.41M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 11 | T. Rowe Price ✦ | 1.97M | +20.6% | $308.85M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 12 | AQR Capital Management ✦ | 1.33M | -6.5% | $206.89M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 13 | Citadel Advisors ✦ | 941.95K | -10.5% | $147.85M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 692.30K | +5.2% | $108.66M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 612.05K | -28.5% | $96.07M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Bridgewater Associates ✦ | 272.03K | +5.1% | $42.70M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 191.58K | +1563.2% | $30.07M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 153.42K | -84.6% | $24.08M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 133.01K | +18.8% | $20.88M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 124.01K | -82.1% | $19.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Marshall Wace ✦ | 66.61K | -96.5% | $10.46M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 22 | Fisher Asset Management ✦ | 2.01K | Nieuw | $315,196 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Fisher Asset Management | $315,196 | 0.0% |
Verlaten
| Norges Bank | $584.42M | was 0.1% |
| Adage Capital Partners | $36.72M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,414 houders, 197.98M aandelen, $39.62B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 6.73K aand · $1.59M
Officer · 16.19K aand · $3.84M
Officer · 6.24K aand · $1.49M
Officer · 6.21K aand · $1.45M
Officer · 3.46K aand · $809,941
Officer · 5.70K aand · $1.34M
Officer · 100 aand · $23,740
Officer · 2.20K aand · $522,733
Officer · 3.90K aand · $915,096
Officer · 10.25K aand · $2.41M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie